131 related articles for article (PubMed ID: 10565012)
21. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
Hélène C
Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
[TBL] [Abstract][Full Text] [Related]
22. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.
Laptev AV; Lu Z; Colige A; Prockop DJ
Biochemistry; 1994 Sep; 33(36):11033-9. PubMed ID: 8086420
[TBL] [Abstract][Full Text] [Related]
23. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
[TBL] [Abstract][Full Text] [Related]
24. Antisense oligonucleotides: is the glass half full or half empty?
Bennett CF
Biochem Pharmacol; 1998 Jan; 55(1):9-19. PubMed ID: 9413924
[TBL] [Abstract][Full Text] [Related]
25. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
27. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
Burch RM; Mahan LC
J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
[TBL] [Abstract][Full Text] [Related]
28. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
Braasch DA; Liu Y; Corey DR
Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540
[TBL] [Abstract][Full Text] [Related]
29. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
[TBL] [Abstract][Full Text] [Related]
31. [In vitro suppression of translation of tick-borne encephalitis virus RNA using antisense nucleotides].
Nomokonova NIu; Gorn VV; Vlasov VV
Mol Biol (Mosk); 1993; 27(2):327-34. PubMed ID: 8487765
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of alpha-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues.
Lin SB; Huang SS; Choo KB; Chen PJ; Au LC
J Biochem; 1995 May; 117(5):1100-4. PubMed ID: 8586626
[TBL] [Abstract][Full Text] [Related]
33. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
34. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
[TBL] [Abstract][Full Text] [Related]
37. ANTISENSE oligonucleotides: a new tool in neuroscience.
Pilowsky PM; Suzuki S; Minson JB
Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):935-44. PubMed ID: 7736652
[TBL] [Abstract][Full Text] [Related]
38. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
39. A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest.
Chen TZ; Lin SB; Wu JC; Choo KB; Au LC
J Biochem; 1996 Feb; 119(2):252-5. PubMed ID: 8882714
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of rheumatoid synovial fibroblast proliferation by antisense oligonucleotides targeting proliferating cell nuclear antigen messenger RNA.
Morita Y; Kashihara N; Yamamura M; Okamoto H; Harada S; Maeshima Y; Okamoto K; Makino H
Arthritis Rheum; 1997 Jul; 40(7):1292-7. PubMed ID: 9214430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
